Tjoung‐Won Park‐Simon

8.9k total citations
46 papers, 629 citations indexed

About

Tjoung‐Won Park‐Simon is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Tjoung‐Won Park‐Simon has authored 46 papers receiving a total of 629 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 16 papers in Pulmonary and Respiratory Medicine and 11 papers in Cancer Research. Recurrent topics in Tjoung‐Won Park‐Simon's work include Ovarian cancer diagnosis and treatment (10 papers), BRCA gene mutations in cancer (9 papers) and Brain Metastases and Treatment (8 papers). Tjoung‐Won Park‐Simon is often cited by papers focused on Ovarian cancer diagnosis and treatment (10 papers), BRCA gene mutations in cancer (9 papers) and Brain Metastases and Treatment (8 papers). Tjoung‐Won Park‐Simon collaborates with scholars based in Germany, United States and Spain. Tjoung‐Won Park‐Simon's co-authors include Peter Hillemanns, Jelena Jaunzeme, Ralf Hass, Stefanie Sperlich, Siegfried Geyer, Thilo Dörk, Hans Christiansen, Loukia M. Spineli, Natalia Bogdanova and Э. К. Хуснутдинова and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Tjoung‐Won Park‐Simon

45 papers receiving 621 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tjoung‐Won Park‐Simon Germany	15	325	208	137	126	93	46	629
Anna Maria Mosconi Italy	13	364 1.1×	140 0.7×	136 1.0×	90 0.7×	134 1.4×	39	558
Karim Malek United States	15	313 1.0×	275 1.3×	155 1.1×	82 0.7×	41 0.4×	30	716
Ana Santaballa Spain	17	337 1.0×	180 0.9×	194 1.4×	138 1.1×	197 2.1×	87	753
Sumitra Ananda Australia	12	224 0.7×	133 0.6×	67 0.5×	85 0.7×	89 1.0×	54	468
Pia Herbolsheimer United States	17	664 2.0×	200 1.0×	101 0.7×	139 1.1×	83 0.9×	32	777
Joyce Varughese United States	15	327 1.0×	203 1.0×	117 0.9×	80 0.6×	62 0.7×	21	628
Christina H. Son United States	11	291 0.9×	167 0.8×	147 1.1×	269 2.1×	195 2.1×	35	888
Robert D. Legare United States	14	449 1.4×	150 0.7×	90 0.7×	68 0.5×	230 2.5×	35	822
Nuria Romero-Laorden Spain	14	491 1.5×	163 0.8×	60 0.4×	275 2.2×	223 2.4×	60	779
Jasmine Bhatia United States	9	318 1.0×	220 1.1×	154 1.1×	274 2.2×	148 1.6×	13	730

Countries citing papers authored by Tjoung‐Won Park‐Simon

Since Specialization

Citations

This map shows the geographic impact of Tjoung‐Won Park‐Simon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tjoung‐Won Park‐Simon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tjoung‐Won Park‐Simon more than expected).

Fields of papers citing papers by Tjoung‐Won Park‐Simon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tjoung‐Won Park‐Simon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tjoung‐Won Park‐Simon. The network helps show where Tjoung‐Won Park‐Simon may publish in the future.

Co-authorship network of co-authors of Tjoung‐Won Park‐Simon

This figure shows the co-authorship network connecting the top 25 collaborators of Tjoung‐Won Park‐Simon. A scholar is included among the top collaborators of Tjoung‐Won Park‐Simon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tjoung‐Won Park‐Simon. Tjoung‐Won Park‐Simon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Krug, David, Joke Tio, Khaled Elsayad, et al.. (2024). The Safety and Efficacy of the Combination of Sacituzumab Govitecan and Palliative Radiotherapy—A Retrospective Multi-Center Cohort Study. Cancers. 16(9). 1649–1649. 5 indexed citations

Marth, Christian, Tjoung‐Won Park‐Simon, Carol Aghajanian, et al.. (2023). #1120 Durvalumab with paclitaxel/carboplatin + bevacizumab then maintenance durvalumab, bevacizumab + olaparib in patients with newly diagnosed advanced ovarian cancer without a tumour BRCA1/2 mutation: results from the DUO-O/ENGOT-Ov46/AGO-OVAR 23/GOG-3025 trial. VBN Forskningsportal (Aalborg Universitet). A428.3–A429. 2 indexed citations

Laakmann, Elena, Tjoung‐Won Park‐Simon, Rudolf Weide, et al.. (2022). Long-term survival of breast cancer patients with brain metastases: subanalysis of the BMBC Registry. Senologie - Zeitschrift für Mammadiagnostik und -therapie. 19(2). e34–e35. 1 indexed citations

Schürmann, Peter, Robert Geffers, Matthias Dürst, et al.. (2020). Germline variation of Ribonuclease H2 genes in ovarian cancer patients. Journal of Ovarian Research. 13(1). 146–146. 1 indexed citations

Schürmann, Peter, Sabin Bhuju, Robert Geffers, et al.. (2017). Assessment of an APOBEC3B truncating mutation, c.783delG, in patients with breast cancer. Breast Cancer Research and Treatment. 162(1). 31–37. 5 indexed citations

Laakmann, Elena, Isabell Witzel, U. Grzyska, et al.. (2016). Radiological Patterns of Brain Metastases in Breast Cancer Patients: A Subproject of the German Brain Metastases in Breast Cancer (BMBC) Registry. International Journal of Molecular Sciences. 17(10). 1615–1615. 20 indexed citations

Hahnen, Eric, Klaus Baumann, André Heimbach, et al.. (2016). Prevalence of somatic mutations in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1 study).. Journal of Clinical Oncology. 34(15_suppl). 5544–5544. 5 indexed citations

Frömke, Cornelia, et al.. (2016). The Benefit of Baseline Staging–Risk Assessment of Distant Breast Cancer Metastases by Tumor Stage. Anticancer Research. 36(9). 4909–4914. 1 indexed citations

Jackisch, Christian, Volkmar Müller, Peter Dall, et al.. (2015). Subcutaneous Trastuzumab for HER2-positive Breast Cancer – Evidence and Practical Experience in 7 German Centers. Geburtshilfe und Frauenheilkunde. 75(6). 566–573. 36 indexed citations

10.

Emons, Günter, Christian Kurzeder, Barbara Schmalfeldt, et al.. (2015). Temsirolimus in women with platinum-refractory/resistant ovarian cancer or advanced/recurrent endometrial carcinoma. A phase II study of the AGO-study group (AGO-GYN8). Gynecologic Oncology. 140(3). 450–456. 49 indexed citations

11.

Emons, Guenter, Christian Kurzeder, Barbara Schmalfeldt, et al.. (2014). Temsirolimus in women with platinum-resistant ovarian cancer or advanced/recurrent endometrial cancer: A multicenter phase II trial of the AGO Study Group (AGO-GYN 8).. Journal of Clinical Oncology. 32(15_suppl). 5565–5565. 2 indexed citations

12.

Bogdanova, Natalia, Peter Schürmann, Marina Bermisheva, et al.. (2014). Mutation Analysis of the ERCC4/FANCQ Gene in Hereditary Breast Cancer. PLoS ONE. 9(1). e85334–e85334. 14 indexed citations

13.

Otte, Anna, et al.. (2014). In vitro and in vivotherapeutic approach for a small cell carcinoma of the ovary hypercalcaemic type using a SCCOHT-1 cellular model. Orphanet Journal of Rare Diseases. 9(1). 126–126. 25 indexed citations

14.

Park‐Simon, Tjoung‐Won, et al.. (2013). Return to work after treatment for primary breast cancer over a 6-year period: results from a prospective study comparing patients with the general population. Supportive Care in Cancer. 21(7). 1901–1909. 61 indexed citations

15.

Bogdanova, Natalia, Marina Bermisheva, Zalina Takhirova, et al.. (2013). Prevalence of PALB2 mutation c.509_510delGA in unselected breast cancer patients from Central and Eastern Europe. Familial Cancer. 13(2). 137–142. 20 indexed citations

16.

Park‐Simon, Tjoung‐Won, et al.. (2012). Kasuistiken zum Mammakarzinom: Eribulin in der hepatisch metastasierten Situation. 3(3). 112–113.

17.

Prokofyeva, Darya, Natalia Bogdanova, Natalia Dubrowinskaja, et al.. (2012). Nonsense mutation p.Q548X in BLM, the gene mutated in Bloom’s syndrome, is associated with breast cancer in Slavic populations. Breast Cancer Research and Treatment. 137(2). 533–539. 43 indexed citations

18.

Otte, Anna, Gudrun Göhring, Doris Steinemann, et al.. (2012). A tumor-derived population (SCCOHT-1) as cellular model for a small cell ovarian carcinoma of the hypercalcemic type. International Journal of Oncology. 41(2). 765–775. 26 indexed citations

19.

Schippert, Cordula, et al.. (2011). The First Description of Docetaxel-Induced Recall Inflammatory Skin Reaction after Previous Drug Extravasation. Annals of Pharmacotherapy. 45(2). 277–277. 3 indexed citations

20.

Kandenwein, J. A., Tjoung‐Won Park‐Simon, Johannes Schramm, & Matthias Simon. (2010). uPA/PAI-1 expression and uPA promoter methylation in meningiomas. Journal of Neuro-Oncology. 103(3). 533–539. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact